![Coronavirus vaccine: Oxford team aim to start lab-controlled human trials | Immunology | The Guardian Coronavirus vaccine: Oxford team aim to start lab-controlled human trials | Immunology | The Guardian](https://i.guim.co.uk/img/media/83c3218b2d8612a50c6df3ab5f3dc644dc5ab6a0/0_118_5472_3282/master/5472.jpg?width=465&dpr=1&s=none)
Coronavirus vaccine: Oxford team aim to start lab-controlled human trials | Immunology | The Guardian
COV009 Study Protocol Version: 3.0_28 Oct 2021 CONFIDENTIAL 1 Trial Title: Post-approval follow-up for the COV001 and 002 trials
![Statement on donation and distribution of Oxford-AstraZeneca COVID-19 vaccine through AVATT – Africa CDC Statement on donation and distribution of Oxford-AstraZeneca COVID-19 vaccine through AVATT – Africa CDC](https://africacdc.org/wp-content/uploads/2021/04/Astra2-1024x568.jpg)
Statement on donation and distribution of Oxford-AstraZeneca COVID-19 vaccine through AVATT – Africa CDC
![Alternating vaccines trial expands to include two additional vaccines | Research | University of Oxford Alternating vaccines trial expands to include two additional vaccines | Research | University of Oxford](https://assets-eu-01.kc-usercontent.com/1aabff82-ce5c-01e4-8a57-218ddbce5058/8e7edd98-b1bf-4c29-8044-5ca61feab73e/ovglogo.jpg?w=600)